Brief: Gensight Biologics End-Sept Cash Position 2.4 Million Euros
Oct 26 (Reuters) - Gensight Biologics SA SIGHT.PA :
* GENSIGHT BIOLOGICS REPORTS CASH POSITION AS OF SEPTEMBER
30,
2023, AND PROVIDES BUSINESS UPDATE
* CASH AND CASH EQUIVALENTS TOTALLED EUR 2.4 MILLION AS OF
SEPTEMBER 30, 2023
Source text for Eikon: ID:nBw9cCQJFa
Further company coverage: SIGHT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gensight Biologics SA
See all newsHealth Rounds: Blindness treatment based on Nobel-winning research shows promise
France's GenSight Biologics H1 net loss widens on higher R&D expenses
Brief: GenSight Biologics H1 Net Income EUR -10.3 Million
France's GenSight Biologics 2025 net loss narrows on reduced R&D spending
Brief: GenSight Biologics FY EPS EUR -0.08